{ "results": [ { "id": "d8dbebf9492a8aade0d80e832cf7e0b6", "title": "Senior Director, Payor and Health Systems Liaison, West", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 264000, "salary_max": 290000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 264000, "base_salary_max": 290000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-01T20:46:51.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Payor and Health Systems Liaison, West Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Field Medical Affairs, the Payor and Health Systems Liaison will own and shape the scientific payer/access strategy for the US region. They will develop and cultivate relationships with key decision-makers and other influencers in managed care organizations, government programs, employers, hospital systems and product distribution companies, to support appropriate patient access and evidence-based utilization for Revolution Medicine's products. A key aspect of the Payor and Health Systems Liaison responsibilities is to keep payers and other key external constituents or influencers abreast of new product launches, line extensions and Medical Affairs research. The Payor and Health Systems Liaison leads high‑impact clinical, scientific, and population health engagement with external access stakeholders, including Payers, Group Purchasing Organizations (GPOs), Community Aggregators, and Integrated Delivery Networks (IDNs), while ensuring strong integration between Medical Affairs, HEOR, and Market Access strategy. Responsibilities", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 12, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.3a47d4b1d257161397", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Payor and Health Systems Liaison, West Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Field Medical Affairs, the Payor and Health Systems Liaison will own and shape the scientific payer/access strategy for the US region. They will develop and cultivate relationships with key decision-makers and other influencers in managed care organizations, government programs, employers, hospital systems and product distribution companies, to support appropriate patient access and evidence-based utilization for Revolution Medicine's products. A key aspect of the Payor and Health Systems Liaison responsibilities is to keep payers and other key external constituents or influencers abreast of new product launches, line extensions and Medical Affairs research. The Payor and Health Systems Liaison leads high‑impact clinical, scientific, and population health engagement with external access stakeholders, including Payers, Group Purchasing Organizations (GPOs), Community Aggregators, and Integrated Delivery Networks (IDNs), while ensuring strong integration between Medical Affairs, HEOR, and Market Access strategy. Responsibilities", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:d8dbebf9492a8aade0d80e832cf7e0b6:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.569e881abcc6f13f79", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Payor and Health Systems Liaison, West Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Field Medical Affairs, the Payor and Health Systems Liaison will own and shape the scientific payer/access strategy for the US region. They will develop and cultivate relationships with key decision-makers and other influencers in managed care organizations, government programs, employers, hospital systems and product distribution companies, to support appropriate patient access and evidence-based utilization for Revolution Medicine's products. A key aspect of the Payor and Health Systems Liaison responsibilities is to keep payers and other key external constituents or influencers abreast of new product launches, line extensions and Medical Affairs research. The Payor and Health Systems Liaison leads high‑impact clinical, scientific, and population health engagement with external access stakeholders, including Payers, Group Purchasing Organizations (GPOs), Community Aggregators, and Integrated Delivery Networks (IDNs), while ensuring strong integration between Medical Affairs, HEOR, and Market Access strategy. Responsibilities", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:d8dbebf9492a8aade0d80e832cf7e0b6:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8ad55e01de09c982c0", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:d8dbebf9492a8aade0d80e832cf7e0b6:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9dd4664ad8414d0439", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:d8dbebf9492a8aade0d80e832cf7e0b6:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.e9158547a9d5297e2a", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution medicines", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:6ea31ccecb17fbc8cc220185", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.adac42b20c47b931b2", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.eab8628592444b44c2", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.9fe5c3e5871cfa096e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:d8dbebf9492a8aade0d80e832cf7e0b6:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648509003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "eb4b9a49c1829518aac469ee3aa06f20", "title": "Executive Director, Healthcare Law and Market Access", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 311000, "salary_max": 357000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 311000, "base_salary_max": 357000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-02T16:37:59.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7648505003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Executive Director, Healthcare Law and Market Access Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an Executive Director, Healthcare Law and Market Access reporting to the Vice President, Healthcare Law to join our RevMed team. The Executive Director, Healthcare Law and Market Access will serve as the zoldonrasib Legal brand lead and provide strategic legal guidance related to the company's planned zoldonrasib commercialization activities, patient access programs, distribution and licensing, and regulatory submissions. In addition, the position will serve as the senior enterprise legal leader responsible for shaping and advancing Revolution Medicines' U.S. Market Access legal strategy in support of commercialization, patient access, pricing, reimbursement, and corporate growth objectives. At a tactical level, the position will be responsible for managing all aspects of Market Access contracting through product distribution channels, including distributors, specialty distributors, specialty pharmacies, 3 rd party logistics providers and payers, and government pricing and reimbursement. A successful candidate will", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.5994c31a3dde74158c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Executive Director, Healthcare Law and Market Access Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an Executive Director, Healthcare Law and Market Access reporting to the Vice President, Healthcare Law to join our RevMed team. The Executive Director, Healthcare Law and Market Access will serve as the zoldonrasib Legal brand lead and provide strategic legal guidance related to the company's planned zoldonrasib commercialization activities, patient access programs, distribution and licensing, and regulatory submissions. In addition, the position will serve as the senior enterprise legal leader responsible for shaping and advancing Revolution Medicines' U.S. Market Access legal strategy in support of commercialization, patient access, pricing, reimbursement, and corporate growth objectives. At a tactical level, the position will be responsible for managing all aspects of Market Access contracting through product distribution channels, including distributors, specialty distributors, specialty pharmacies, 3 rd party logistics providers and payers, and government pricing and reimbursement. A successful candidate will", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:eb4b9a49c1829518aac469ee3aa06f20:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e56aabaf0acb0b0505", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Executive Director, Healthcare Law and Market Access Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an Executive Director, Healthcare Law and Market Access reporting to the Vice President, Healthcare Law to join our RevMed team. The Executive Director, Healthcare Law and Market Access will serve as the zoldonrasib Legal brand lead and provide strategic legal guidance related to the company's planned zoldonrasib commercialization activities, patient access programs, distribution and licensing, and regulatory submissions. In addition, the position will serve as the senior enterprise legal leader responsible for shaping and advancing Revolution Medicines' U.S. Market Access legal strategy in support of commercialization, patient access, pricing, reimbursement, and corporate growth objectives. At a tactical level, the position will be responsible for managing all aspects of Market Access contracting through product distribution channels, including distributors, specialty distributors, specialty pharmacies, 3 rd party logistics providers and payers, and government pricing and reimbursement. A successful candidate will", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:eb4b9a49c1829518aac469ee3aa06f20:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6168770f533d9c1e8b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:eb4b9a49c1829518aac469ee3aa06f20:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fe26b0c29cca927c82", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:eb4b9a49c1829518aac469ee3aa06f20:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.39c731b01907831cf5", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution medicines", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:daf94dadb3f97caa75dbf6c4", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.03c618cb4301efd910", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.bca5178e68865ab25c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.a6dda9230e3038f963", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "eb4b9a49c1829518aac469ee3aa06f20", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:eb4b9a49c1829518aac469ee3aa06f20:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648505003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648505003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648505003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648505003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648505003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7648505003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "ce350a32a4f8d921672945862f039e5a", "title": "Senior Director, Responsible Pharmacist (Pharmacien Responsable), France", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (France)", "country": "FR", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "unknown", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:41:18.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7694372003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Responsible Pharmacist (Pharmacien Responsable), France Remote (France) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: General Purpose The Senior Director, Head Pharmacist/Responsible Pharmacist guarantees the pharmaceutical responsibility of the laboratory as “exploitant” (see definition of the “exploitant”, Article R.5124-2, 3 ° of the French Public Health Code) and assumes the role of \"Responsible Pharmacist\" as described in Article R.5124-36 of the Public Health Code. Responsibilities include: - Organize and supervise all pharmaceutical operations of the company or organization, including manufacturing, advertising, information, pharmacovigilance, batch monitoring and withdrawal, distribution, import and export of the drugs, products, objects or articles concerned, as well as the corresponding storage operations. - Ensure that transport conditions guarantee the proper preservation, integrity and safety of these medicines, products, objects or articles. - Acknowledge the files related to marketing authorization applications submitted by Corporate or organization and any other application related to the activities they organize and supervise. - Participate in the development of research", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.bd6a6472ce1112ba22", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "ce350a32a4f8d921672945862f039e5a", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution medicines", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:b5b41f82c7a292c74ca02fe6", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7ca94025c22a150f0e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "ce350a32a4f8d921672945862f039e5a", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c5f4e250d71df84bc2", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "ce350a32a4f8d921672945862f039e5a", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.d5ca6db6304654b731", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "ce350a32a4f8d921672945862f039e5a", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:ce350a32a4f8d921672945862f039e5a:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694372003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694372003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694372003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694372003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "4303ec875c72ef224f72a62a7eabb479", "title": "Executive Director, AI/ML Drug Discovery Analytics", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 326000, "salary_max": 383000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 326000, "base_salary_max": 383000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:43:35.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7695158003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Executive Director, AI/ML Drug Discovery Analytics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As Executive Director, AI/ML Drug Discovery Analytics, you will be a senior leader shaping the future of data-driven drug discovery at Revolution Medicines. You will define the Research's AI/ML strategy, oversee implementation of advanced analytics across discovery and build a world-class team to unlock the full potential of our rich internal datasets and make these insights accessible to other scientist. Your leadership will directly influence early discovery innovation, pipeline acceleration, and strategic portfolio decisions. Responsibilities include: Technical Leadership and Innovation: You will have a deep understanding of Machine Learning Operations and AI system design. Design and scale a robust ML infrastructure, integrating MLOps best practices to ensure seamless development, deployment, and monitoring of AI/ML models. Drive innovation in applying deep learning, generative models, and diffusion models to drug discovery, including target prediction, hit identification, and lead optimization. Leverage RevMed's unique datasets", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "data", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.8583bcf238bd7c15a8", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "4303ec875c72ef224f72a62a7eabb479", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution medicines", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:ba5d21f81aeb00811a703ab1", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.17e31be13fdb0eb221", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "4303ec875c72ef224f72a62a7eabb479", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2aa1c211fe37805d59", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "4303ec875c72ef224f72a62a7eabb479", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.c2a15af64e5b4c3190", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "4303ec875c72ef224f72a62a7eabb479", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "data", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:4303ec875c72ef224f72a62a7eabb479:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695158003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695158003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695158003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695158003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695158003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "fba147aa97eb851c96d9bfea0c4e1b06", "title": "Associate Director, Clinical Operations Compliance & Training", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 186000, "salary_max": 233000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 186000, "base_salary_max": 233000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-29T00:00:36.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7684892003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Clinical Operations Compliance & Training Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As an Associate Director, you will be responsible for the following: - Lead and/or support development and implementation of GCP systems and inspection readiness. - Lead and/or support the development and continuous improvement of Clinical Policies/ SOPs/ WIs/ Templates/etc. using knowledge and experience with clinical study management, International Conference on Harmonization (ICH) Guidelines, Good Clinical Practices (GCP) and regulatory requirements. - SME for", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 25, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.7b3caaa5a7494af6b0", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Clinical Operations Compliance & Training Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As an Associate Director, you will be responsible for the following: - Lead and/or support development and implementation of GCP systems and inspection readiness. - Lead and/or support the development and continuous improvement of Clinical Policies/ SOPs/ WIs/ Templates/etc. using knowledge and experience with clinical study management, International Conference on Harmonization (ICH) Guidelines, Good Clinical Practices (GCP) and regulatory requirements. - SME for", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fba147aa97eb851c96d9bfea0c4e1b06:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.db0a5c039dfd72dd8c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Clinical Operations Compliance & Training Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As an Associate Director, you will be responsible for the following: - Lead and/or support development and implementation of GCP systems and inspection readiness. - Lead and/or support the development and continuous improvement of Clinical Policies/ SOPs/ WIs/ Templates/etc. using knowledge and experience with clinical study management, International Conference on Harmonization (ICH) Guidelines, Good Clinical Practices (GCP) and regulatory requirements. - SME for", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fba147aa97eb851c96d9bfea0c4e1b06:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.53eb97d02fb39362f6", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fba147aa97eb851c96d9bfea0c4e1b06:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c3141cd12acf71c8f5", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fba147aa97eb851c96d9bfea0c4e1b06:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.515f84ee1304c9d849", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution medicines", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:eeda9c37d5c605ddddec7daa", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e68fd8339b67f59212", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ee05e231ffc83bedbc", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.177ead466595ca1004", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fba147aa97eb851c96d9bfea0c4e1b06", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fba147aa97eb851c96d9bfea0c4e1b06:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7684892003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7684892003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7684892003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7684892003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7684892003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "bf23d2273f2e27b972048096a556da08", "title": "Associate Director, Global Omnichannel Solutions Delivery", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 186000, "salary_max": 233000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 186000, "base_salary_max": 233000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-22T18:37:56.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7655280003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Global Omnichannel Solutions Delivery Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: RevMed is seeking a strategic and experienced technology leader to join our Information Sciences (IS) team as Associate Director, Global Omnichannel Solutions Delivery. This role will ensure our omnichannel technology ecosystem is connected, scalable, and globally ready, enabling seamless customer experiences across markets outside of the US. The individual will play a critical role in supporting global expansion by establishing scalable solutions, enabling adoption of global platforms, and ensuring new capabilities, brands, and regions can be added efficiently without rework or fragmentation. The ideal candidate brings strong technical acumen, experience working across multiple marketing technologies, and the ability to translate complex business needs into scalable, globally consistent solutions. Key responsibilities: Global Omnichannel Enablement - Lead deployment of integrated customer journeys across ex-US markets, ensuring alignment with global platform strategy. - Enable launch, medical, and global expansion priorities through scalable solution enablement.", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": null, "role_function": "engineering", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "growth-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.683d5d3ad1beae40a1", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "bf23d2273f2e27b972048096a556da08", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution medicines", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:7f2cafbc637f7542b721beda", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c0afb2eea9d415c378", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "bf23d2273f2e27b972048096a556da08", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ffc2d394a5c23db514", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "bf23d2273f2e27b972048096a556da08", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.47169bee5619feb44b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "bf23d2273f2e27b972048096a556da08", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "engineering", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:bf23d2273f2e27b972048096a556da08:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7655280003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7655280003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7655280003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7655280003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7655280003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7655280003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "5d607d9bb10f5fdb9dda0981636feba5", "title": "Scientist II, Drug Product", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 132000, "salary_max": 166000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 132000, "base_salary_max": 166000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:45:46.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7695483003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Scientist II, Drug Product Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking Scientist II to join the Drug Product team within Pharmaceutical Development & Manufacturing (PDM). This role will support the development of solid oral dosage forms for small molecule programs across the RVMD pipeline. The successful candidate will contribute to formulation and process development activities from early-stage through late-stage clinical/commercial development, working closely with cross-functional partners and CDMOs to ensure robust, scalable, and compliant drug product manufacturing processes. Key Responsibilities: - Contribute to drug product development activities for new chemical entities (NCEs) from early development through late-stage clinical development, with exposure to commercialization activities. - Design and execute drug product development and manufacturing activities for solid oral dosage forms, including: - Preformulation and formulation development. - Manufacturing process development. - Process scale-up, technology transfer, and process optimization. - Process validation and commercial manufacturing support. - Support outsourced development and GMP", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 3, "years_experience_max": 7, "role_function": "product", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.64648e7ac2d71a44c8", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "5d607d9bb10f5fdb9dda0981636feba5", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a63bab9819c8d8b0c7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "5d607d9bb10f5fdb9dda0981636feba5", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.de62c5afcd5ddf0b8c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "5d607d9bb10f5fdb9dda0981636feba5", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "product", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:5d607d9bb10f5fdb9dda0981636feba5:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695483003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695483003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695483003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695483003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695483003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695483003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "3ac182eb19196a65db61ceb512d21e3a", "title": "Director, Medical Science Liaison (Dallas, AR, LA, OK, MS)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-19T07:27:40.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (Dallas, AR, LA, OK, MS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0e8e9f0509e19152de", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3ac182eb19196a65db61ceb512d21e3a", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Dallas, AR, LA, OK, MS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3ac182eb19196a65db61ceb512d21e3a:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.50bca7c762f8985ebd", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3ac182eb19196a65db61ceb512d21e3a", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Dallas, AR, LA, OK, MS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3ac182eb19196a65db61ceb512d21e3a:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.38e51e71adbdcfc153", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3ac182eb19196a65db61ceb512d21e3a", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3ac182eb19196a65db61ceb512d21e3a:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.db946cc4d057cdfb7b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3ac182eb19196a65db61ceb512d21e3a", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3ac182eb19196a65db61ceb512d21e3a:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.46198672cccca32cf4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3ac182eb19196a65db61ceb512d21e3a", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.724d4107930ac47200", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3ac182eb19196a65db61ceb512d21e3a", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739035003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "7c31abdf3e3ef9d7c9ce4658312ec600", "title": "Principal Product Manager, Real World Evidence Intelligence", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 186000, "salary_max": 233000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 186000, "base_salary_max": 233000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-19T06:00:51.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7738983003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Principal Product Manager, Real World Evidence Intelligence Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Principal Product Manager, Real-World Evidence Intelligence to shape products and capabilities that help teams use real-world data to design better studies, evaluate feasibility, support regulatory and evidence strategies, communicate value, and monitor outcomes across the product lifecycle. This role will define and deliver RWE Intelligence capabilities through the right mix of internal products, RevCore platform capabilities, external data assets, SaaS platforms, vendor partnerships, and integrations. The mandate is to improve study design, protocol feasibility, enrollment assumptions, external comparator readiness, evidence generation speed, value communication, and post-approval monitoring. You will work on high-impact capabilities where data fitness, transparency, reproducibility, and speed directly affect clinical development decisions, regulatory confidence, access strategy, and patient impact. Own RWE Intelligence strategy and measurable outcomes - Define the vision and roadmap for RWE products and capabilities across clinical development, regulatory, medical, HEOR,", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "principal", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 12, "years_experience_max": null, "role_function": "product", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6998c21545e350a44c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7c31abdf3e3ef9d7c9ce4658312ec600", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6bc0713db9fc457be1", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7c31abdf3e3ef9d7c9ce4658312ec600", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.06f825b23e4248e217", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7c31abdf3e3ef9d7c9ce4658312ec600", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "product", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:7c31abdf3e3ef9d7c9ce4658312ec600:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7738983003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7738983003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7738983003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7738983003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7738983003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7738983003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "a860cd4b425f7d344257ea43b0c913ef", "title": "Principal Scientist, Cancer Pharmacology, Translational Research", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 190000, "salary_max": 238000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 190000, "base_salary_max": 238000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-21T23:49:41.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7746574003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Principal Scientist, Cancer Pharmacology, Translational Research Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Principal Scientist in the Cancer Pharmacology team within the Translational Research group, in the Biomedical Discovery Research Department, you will: - Provide scientific and strategic leadership for RAS(ON) inhibitor programs by translating mechanistic insights in RAS biology into impactful pharmacology strategies and translational study plans. - Lead, mentor, and develop a high-performing group of in vivo scientists, fostering scientific excellence, innovation, and cross-functional collaboration. - Drive the design, execution, and interpretation of in vivo efficacy and PK/PD studies conducted internally and through external partners to advance oncology discovery and development programs. - Partner closely with the cross-functional quantitative modeling group to provide biological insight, translational context, and critical evaluation supporting PK/PD modeling efforts. - Influence portfolio progression through generation of high-impact data packages and contributions to regulatory submissions. - Serve as the in vivo pharmacology expert on cross-functional project", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "principal", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 12, "role_function": "teaching_education", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ceef5de153823a1c05", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a860cd4b425f7d344257ea43b0c913ef", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.dde7d0ca1d73f49ccf", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a860cd4b425f7d344257ea43b0c913ef", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.508fed77d79905e7bc", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a860cd4b425f7d344257ea43b0c913ef", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "teaching_education", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:a860cd4b425f7d344257ea43b0c913ef:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7746574003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7746574003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7746574003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7746574003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7746574003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7746574003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "293ab162a78995599054c8424438eff4", "title": "Director, Stability Management, Analytical Development and Quality Control", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 211000, "salary_max": 264000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 211000, "base_salary_max": 264000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-23T20:50:05.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7712471003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Stability Management, Analytical Development and Quality Control Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as the stability program lead, the position will be responsible for oversight and management of outsourced stability studies conducted. The director, stability is a self-motivated individual who works as a member of an integrated team contracting, designing, managing, and evaluating stability studies at contractors for both drug substance and drug product. This individual should have the breadth of experience required to manage stability studies in commercial, late and early clinical development stage. This individual should have broad knowledge of ICH and cGMP guidelines and the ability to contribute to global regulatory filings for stability. - Develop and implement the strategic direction of stability programs in alignment with ICH guidelines and regulatory expectations. - Oversee the design, execution, and management of stability studies (development, registration and commercial). - Work cross functionally with CMC, quality, regulatory, clinical", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 12, "years_experience_max": 12, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.5708735d153de36e33", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "293ab162a78995599054c8424438eff4", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.98d8e46ca5e23e55da", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "293ab162a78995599054c8424438eff4", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.1d8af08677836582de", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "293ab162a78995599054c8424438eff4", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:293ab162a78995599054c8424438eff4:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7712471003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7712471003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7712471003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7712471003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7712471003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7712471003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "8aea234391d33966bdb3186f4dddae28", "title": "Director, Medical Science Liaison (Northern Florida, GA, SC, AL, MS)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-14T22:14:45.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (Northern Florida, GA, SC, AL, MS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.1772d4fc1d643650d0", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8aea234391d33966bdb3186f4dddae28", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Northern Florida, GA, SC, AL, MS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8aea234391d33966bdb3186f4dddae28:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.d49761370db1c84a8d", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8aea234391d33966bdb3186f4dddae28", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Northern Florida, GA, SC, AL, MS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8aea234391d33966bdb3186f4dddae28:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3aab5b37ad0d026a8f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8aea234391d33966bdb3186f4dddae28", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8aea234391d33966bdb3186f4dddae28:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f1d277abca069e9b2f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8aea234391d33966bdb3186f4dddae28", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8aea234391d33966bdb3186f4dddae28:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.522bdc3f5af1b38336", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8aea234391d33966bdb3186f4dddae28", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e676c3434257d5d8cb", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8aea234391d33966bdb3186f4dddae28", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734091003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "8c2dcbfea8d976f95623491d5187b77d", "title": "Executive Director, Early Clinical Development", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 265000, "salary_max": 331000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 265000, "base_salary_max": 331000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-15T17:13:01.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7720361003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Executive Director, Early Clinical Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced drug developer and effective leader to serve as Executive Director of Early Clinical Development in support of Revolution Medicines' clinical-stage molecule(s) and/or pre-clinical molecule(s). In this critical role, you will be responsible for developing the strategic plans and ensuring efficient operational execution of the molecule(s)' clinical development program in one or more disease indications, from early-stage studies to regulatory submissions and potential commercialization. You will play a pivotal role in shaping the future of our pipeline and driving the development of transformative therapies for patients. - Provide critical insights/contributions and implement comprehensive/execute upon the clinical development plans for Revolution Medicines' molecules, ensuring alignment with scientific, regulatory, and commercial objectives. - Lead, mentor, and manage a high-performing cross-functional team of clinical development professionals, fostering a culture of collaboration, innovation, and excellence. - Oversee all aspects of clinical trial", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.2d2316cf30c3abb5f3", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8c2dcbfea8d976f95623491d5187b77d", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Executive Director, Early Clinical Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced drug developer and effective leader to serve as Executive Director of Early Clinical Development in support of Revolution Medicines' clinical-stage molecule(s) and/or pre-clinical molecule(s). In this critical role, you will be responsible for developing the strategic plans and ensuring efficient operational execution of the molecule(s)' clinical development program in one or more disease indications, from early-stage studies to regulatory submissions and potential commercialization. You will play a pivotal role in shaping the future of our pipeline and driving the development of transformative therapies for patients. - Provide critical insights/contributions and implement comprehensive/execute upon the clinical development plans for Revolution Medicines' molecules, ensuring alignment with scientific, regulatory, and commercial objectives. - Lead, mentor, and manage a high-performing cross-functional team of clinical development professionals, fostering a culture of collaboration, innovation, and excellence. - Oversee all aspects of clinical trial", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8c2dcbfea8d976f95623491d5187b77d:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c0b4d2bf919a0d452e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8c2dcbfea8d976f95623491d5187b77d", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Executive Director, Early Clinical Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced drug developer and effective leader to serve as Executive Director of Early Clinical Development in support of Revolution Medicines' clinical-stage molecule(s) and/or pre-clinical molecule(s). In this critical role, you will be responsible for developing the strategic plans and ensuring efficient operational execution of the molecule(s)' clinical development program in one or more disease indications, from early-stage studies to regulatory submissions and potential commercialization. You will play a pivotal role in shaping the future of our pipeline and driving the development of transformative therapies for patients. - Provide critical insights/contributions and implement comprehensive/execute upon the clinical development plans for Revolution Medicines' molecules, ensuring alignment with scientific, regulatory, and commercial objectives. - Lead, mentor, and manage a high-performing cross-functional team of clinical development professionals, fostering a culture of collaboration, innovation, and excellence. - Oversee all aspects of clinical trial", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8c2dcbfea8d976f95623491d5187b77d:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.35140501e18171f580", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8c2dcbfea8d976f95623491d5187b77d", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8c2dcbfea8d976f95623491d5187b77d:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ed44da09238365f95c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8c2dcbfea8d976f95623491d5187b77d", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:8c2dcbfea8d976f95623491d5187b77d:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7ca25e81c8787c85a6", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8c2dcbfea8d976f95623491d5187b77d", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7fb4709d45b658e6b4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "8c2dcbfea8d976f95623491d5187b77d", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7720361003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7720361003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7720361003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7720361003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7720361003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7720361003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "a7483daadde7fd04a7bb51ccf0509fd7", "title": "Director, Medical Science Liaison (Northern California, Hawaii)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-14T22:14:48.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (Northern California, Hawaii) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.7ff58e622bea7f8ec0", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a7483daadde7fd04a7bb51ccf0509fd7", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Northern California, Hawaii) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:a7483daadde7fd04a7bb51ccf0509fd7:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.83271fbd4b8c4d4f27", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a7483daadde7fd04a7bb51ccf0509fd7", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Northern California, Hawaii) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:a7483daadde7fd04a7bb51ccf0509fd7:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1f87a3dc4ab7487a94", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a7483daadde7fd04a7bb51ccf0509fd7", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:a7483daadde7fd04a7bb51ccf0509fd7:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a53d48d7f410fb059f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a7483daadde7fd04a7bb51ccf0509fd7", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:a7483daadde7fd04a7bb51ccf0509fd7:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.829d31b82b652c5847", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a7483daadde7fd04a7bb51ccf0509fd7", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ed8d4beaa0428bb7ed", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a7483daadde7fd04a7bb51ccf0509fd7", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734115003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "d005a44c3b8ab85213b5e3db8e22185e", "title": "Director, Medical Information", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 201000, "salary_max": 251000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 201000, "base_salary_max": 251000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:36:39.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Information Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a motivated and experienced professional to join our team as a Director of Medical Information. This role focuses on ensuring the delivery of timely, accurate, and evidence-based responses to healthcare professionals (HCPs), patients, and caregivers. As a key member of the Medical Affairs team, you will oversee the creation and management of medical information content, support compendia submissions, and provide Medical Information support at congresses. The ideal candidate is a skilled communicator with a strong scientific background and can manage projects in a dynamic environment. Key Responsibilities: - Lead oversight and performance management of the global Medical Information call center, ensuring all customer inquiries are handled accurately, compliantly and within established timelines. - Maintains and monitors KPIs, and quality metrics, driving continuous improvement to ensure high-quality, consistent inquiry handling. - Prepares and presents regular reports on medical information performance metrics and outcomes to", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 7, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6124d6a4e262cae664", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d005a44c3b8ab85213b5e3db8e22185e", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e68e9da60b47a5f085", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d005a44c3b8ab85213b5e3db8e22185e", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.fdab74241a44f5da5e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d005a44c3b8ab85213b5e3db8e22185e", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:d005a44c3b8ab85213b5e3db8e22185e:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "rule:remote_status" ], "checked_at": null }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "3c43e27f00377d0c420c484d3a16db35", "title": "Research Associate II, Proteomics", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 91000, "salary_max": 110000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 91000, "base_salary_max": 110000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-28T00:10:54.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7750162003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Research Associate II, Proteomics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated and detail-oriented individual to support mass spectrometry-based proteomics workflows. This is an excellent opportunity for an early-career scientist to gain hands-on experience in proteomics within a drug discovery environment. This role will focus on executing established laboratory workflows, maintaining high-quality data standards, and supporting the development of new capabilities within the team. Training will be provided for specialized techniques and instrumentation. In this role, success will come from consistently executing workflows with accuracy, maintaining well-documented experiments, and building technical proficiency over time. As a key member of the Proteomics group within our dynamic Chemical Biology team, you will: - Perform sample preparation for bottom-up proteomics workflows using established protocols with high attention to detail and consistency. - Execute and help improve automated proteomics workflows. - Support routine instrument operation, maintenance and quality control of LC and MS/MS", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 3, "years_experience_max": 7, "role_function": "other", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.93de356d1b0b00fc1a", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3c43e27f00377d0c420c484d3a16db35", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b10609923421eb00f6", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3c43e27f00377d0c420c484d3a16db35", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.401b24f290fcc61430", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3c43e27f00377d0c420c484d3a16db35", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "other", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3c43e27f00377d0c420c484d3a16db35:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7750162003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7750162003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7750162003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7750162003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7750162003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "c105e3535b716e6f76407b9a11159eb9", "title": "Associate Director, HEOR, Japan", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (Japan)", "country": "JP", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "unknown", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-09T22:14:25.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "growth-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0e45a1a6aae60e0f9d", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.fdde5c8d8ba975d3e1", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.09822d523b7559b1d4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.38c6c4ede4cdf0a0b7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2699fed29bc77a6407", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6177ddcc8b382b38a4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "c2668784570c9d5b73bccc5765d8179f", "title": "Director, Medical Science Liaison (Southern California)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-14T22:14:05.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (Southern California) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0757cb19af8e694f64", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c2668784570c9d5b73bccc5765d8179f", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Southern California) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c2668784570c9d5b73bccc5765d8179f:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.71e79255019b5d3216", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c2668784570c9d5b73bccc5765d8179f", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (Southern California) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c2668784570c9d5b73bccc5765d8179f:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b9cf7c4c1441ebfc7d", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c2668784570c9d5b73bccc5765d8179f", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c2668784570c9d5b73bccc5765d8179f:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c94defc2e661a8f0f6", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c2668784570c9d5b73bccc5765d8179f", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c2668784570c9d5b73bccc5765d8179f:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2096270ff2be8698db", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c2668784570c9d5b73bccc5765d8179f", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a147522232cfcefef7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c2668784570c9d5b73bccc5765d8179f", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734105003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "93a9f546df4ddd1ef76b292d6ece1c4e", "title": "Director, Clinical Quality", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 201000, "salary_max": 251000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 201000, "base_salary_max": 251000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:29:26.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Clinical Quality Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director of Clinical Quality will play a key role in Quality Assurance and have direct responsibility for the clinical quality workstreams and study teams. This role is responsible for providing quality and compliance oversight for RevMed-sponsored clinical trials with respect to RevMed's Standard Operating Procedures, applicable regulatory requirements (FDA, EU, ICH & country-specific), and current industry standards and practices. This role will support daily compliance operational activities, evaluate risk, and resolve quality events for early phase through late-phase clinical programs. This role will also be responsible for managing multiple studies including GLP activities that impact clinical studies/data. This role will report to the Head of Clinical Quality. - Act as the study lead for Phase 3 program(s), provide support and guidance to the Clinical Development and Clinical Operations functions, including but not limited to the following functional areas: Global Patient Safety, Translational Medicine,", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.34adcd0f08e9f56a3c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fd55574b2e25f18330", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.07475b84d92614c76e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:93a9f546df4ddd1ef76b292d6ece1c4e:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "f106c4f2159a0f9119e40bd09b4eb568", "title": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-19T07:33:15.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e632ef473fc91f678c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.ef613fd2acecbe1bda", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0e76154a60f4b302ff", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.655eea3a8fe3974142", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d0c5704e43e0f7ae5c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.db502c1a6c8988fbad", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "f0dc5f1a65b63a3dc99d009006b44864", "title": "Senior Director, Biostatistics, Europe", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (Switzerland)", "country": "CH", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:35:28.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Biostatistics, Europe Remote (Switzerland) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and the subject matter expert (SME) in Biostatistics within the Quantitative Sciences function, this position is to provide statistical leadership and support for EU access strategies, healthcare technology assessments and regulatory submissions. - Serve as the statistical lead for European access strategies, ensuring alignment between Global Clinical Development, European regulatory (EMA, MHRA, Swissmedic...) and regional/local Market Access needs to support successful European launches in collaboration with global and regional crossfunctional teams. - Partner with Regional and Local Market Access and HEOR functions to design and lead/oversee the execution of statistical analyses required for value dossiers, including PICO, indirect treatment comparisons, network meta-analyses, and RWE generation. - Partner closely with the development statistical lead, provide statistical support for EU regulatory interactions, including EMA Scientific Advice, MAA, Type II variations, and post-authorization commitments. - Ensure statistical methodologies", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 12, "role_function": "data", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cc7d63c044670c2db4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f0dc5f1a65b63a3dc99d009006b44864", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ec169d3185750aff75", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f0dc5f1a65b63a3dc99d009006b44864", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.6804da8b141bb86a71", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f0dc5f1a65b63a3dc99d009006b44864", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "data", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f0dc5f1a65b63a3dc99d009006b44864:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "fe67fffa8f0de0487f438e51c90baa42", "title": "Director, Medical Science Liaison (MI, WI, MN)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-14T22:14:28.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (MI, WI, MN) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.1ef360498b66dfe2e7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (MI, WI, MN) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.9a02a229efd3d6b0ae", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (MI, WI, MN) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.63529583dbd31122c7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fd5325da1f564d2968", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.783905cdee56d58756", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f6a88b5251c4b1b601", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "24070f2483e4550fbf011fdd966c0d31", "title": "Director, Global Pre-Approval Patient Access", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 201000, "salary_max": 251000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 201000, "base_salary_max": 251000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-27T00:15:42.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7613323003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Global Pre-Approval Patient Access Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director of Global Pre-Approval Patient Access will lead the strategy, design, and execution of global early access programs for Revolution Medicines' pipeline. This role is critical to enabling appropriate patient access to investigational therapies targeting RAS-addicted cancers while ensuring alignment with clinical development/operations, regulatory requirements, and company priorities. This role will report into the Head of Advocacy and Society Engagement and play an integral role in our commitment to supporting appropriate patient access to medicines. - Develop and support global early access strategy aligned with clinical and regulatory milestones; ensure distinction with other patient access initiatives considered or implemented. - Design and implement free of charge named-patient and cohort early access programs globally. - Serve as overall cross-functional leader of the programs, liaising across Clinical, Regulatory, Medical Affairs, Commercial, Legal, Supply Chain, as needed. - Establish governance for global evaluation , and prioritization", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.885df3b10f99dac090", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24070f2483e4550fbf011fdd966c0d31", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Global Pre-Approval Patient Access Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director of Global Pre-Approval Patient Access will lead the strategy, design, and execution of global early access programs for Revolution Medicines' pipeline. This role is critical to enabling appropriate patient access to investigational therapies targeting RAS-addicted cancers while ensuring alignment with clinical development/operations, regulatory requirements, and company priorities. This role will report into the Head of Advocacy and Society Engagement and play an integral role in our commitment to supporting appropriate patient access to medicines. - Develop and support global early access strategy aligned with clinical and regulatory milestones; ensure distinction with other patient access initiatives considered or implemented. - Design and implement free of charge named-patient and cohort early access programs globally. - Serve as overall cross-functional leader of the programs, liaising across Clinical, Regulatory, Medical Affairs, Commercial, Legal, Supply Chain, as needed. - Establish governance for global evaluation , and prioritization", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24070f2483e4550fbf011fdd966c0d31:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.a92ea9bc149994e25d", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24070f2483e4550fbf011fdd966c0d31", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Global Pre-Approval Patient Access Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director of Global Pre-Approval Patient Access will lead the strategy, design, and execution of global early access programs for Revolution Medicines' pipeline. This role is critical to enabling appropriate patient access to investigational therapies targeting RAS-addicted cancers while ensuring alignment with clinical development/operations, regulatory requirements, and company priorities. This role will report into the Head of Advocacy and Society Engagement and play an integral role in our commitment to supporting appropriate patient access to medicines. - Develop and support global early access strategy aligned with clinical and regulatory milestones; ensure distinction with other patient access initiatives considered or implemented. - Design and implement free of charge named-patient and cohort early access programs globally. - Serve as overall cross-functional leader of the programs, liaising across Clinical, Regulatory, Medical Affairs, Commercial, Legal, Supply Chain, as needed. - Establish governance for global evaluation , and prioritization", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24070f2483e4550fbf011fdd966c0d31:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.176b35bf580ac8a57b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24070f2483e4550fbf011fdd966c0d31", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24070f2483e4550fbf011fdd966c0d31:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.415c4061976d5f4e71", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24070f2483e4550fbf011fdd966c0d31", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24070f2483e4550fbf011fdd966c0d31:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0229660c9c93a55e86", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24070f2483e4550fbf011fdd966c0d31", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e17b90f70365a1e5eb", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24070f2483e4550fbf011fdd966c0d31", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7613323003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7613323003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7613323003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7613323003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7613323003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7613323003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "b983ea3a1fb38d8c8284bdecc00d8a23", "title": "Senior Director, Commercial Drug Product Manufacturing Operations", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 244000, "salary_max": 305000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 244000, "base_salary_max": 305000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-10T17:16:33.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Commercial Drug Product Manufacturing Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Commercial Drug Product Manufacturing Operations will lead commercial drug product manufacturing and primary packaging activities within the Drug Product Development & Manufacturing organization. The role will oversee execution of commercial manufacturing operations across external manufacturing and packaging partners to support reliable commercial supply and lifecycle management. Responsibilities include commercial readiness activities, site qualification, technology transfer, process validation, PPQ execution, post-approval changes, troubleshooting, continued process verification (CPV), and operational excellence initiatives. The role will also support execution of commercial process monitoring activities to ensure sustained process performance and product quality. Responsibilities: - Lead execution of commercial manufacturing and primary packaging operations across CMOs and packaging partners. - Lead implementation of post-approval manufacturing and packaging changes. - Lead execution of continued process verification (CPV) activities across commercial manufacturing operations. - Manage monitoring and trending of critical process parameters, process", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 15, "years_experience_max": null, "role_function": "product", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4edfd71f0ab5f92b9e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c57f2062a292d37279", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.6dd14d13d6b5ec4897", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "product", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:b983ea3a1fb38d8c8284bdecc00d8a23:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } } ], "total": 199, "page": 2, "per_page": 24, "applied_filters": { "q": "Revolution Medicines" }, "hidden_unknown_benefits_count": 0, "hidden_quality_floor_count": 0, "quality_floor": "default", "search_profile": { "profile_id": "inv382.d6.pg_textsearch_bge_small_rrf.v1", "bm25_extension": "pg_textsearch", "vector_model": "BAAI/bge-small-en-v1.5", "vector_model_version": "v1.5", "fusion_method": "rrf" }, "explanation_context": { "non_trivial_query": true, "query_terms": [ "revolution", "medicines" ], "active_filter_keys": [], "visible_signal_limit": 3, "visible_trust_limit": 2 }, "event_context": { "query_context": { "query_id": "2772f13b-5f16-447b-bf94-4dda76d86189", "issued_at": "2026-08-11T04:20:16.481Z", "route": "/jobs", "page": 2, "per_page": 24, "total_results": 199, "sort": "relevance", "ranking_policy": "hybrid_rrf_rerank", "ranking_policy_version": "inv382.jobs.search.v2", "query_hash": "hmac_sha256:OdtlEs6N_GFMGtR5mDTNg_XhKGC5gY4zTKwsBLXzhFs", "filter_hash": "hmac_sha256:6CBErDPXOFVCSNkSGbTmuw6GxoMjwSLro0KqZMtxL_0", "query_features": { "has_q": true, "q_term_count": 2, "q_length_bucket": "16_40", "q_pii_redacted": false, "state_count": 0, "benefit_filters": [], "quality_floor": "default" }, "exposures": [ { "result_id": "d8dbebf9492a8aade0d80e832cf7e0b6", "position": 25, "page_position": 1, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0.29587703943252563, "rrf_score": 0.020634920634920638, "rerank_score": 0.5938002467155457, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 101, "quality_score": 55 } }, { "result_id": "eb4b9a49c1829518aac469ee3aa06f20", "position": 26, "page_position": 2, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0.29860834487626753, "rrf_score": 0.01896117900790798, "rerank_score": 0.36627277731895447, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 69, "quality_score": 55 } }, { "result_id": "ce350a32a4f8d921672945862f039e5a", "position": 27, "page_position": 3, "retrieval_features": { "bm25_score": 0, "vector_score": 0.28492168874015156, "rrf_score": 0.014705882352941176, "rerank_score": 0.006826408207416534, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 122, "quality_score": 45 } }, { "result_id": "4303ec875c72ef224f72a62a7eabb479", "position": 28, "page_position": 4, "retrieval_features": { "bm25_score": 0, "vector_score": 0.28297680616378784, "rrf_score": 0.015151515151515152, "rerank_score": -0.36292764544487, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 122, "quality_score": 55 } }, { "result_id": "fba147aa97eb851c96d9bfea0c4e1b06", "position": 29, "page_position": 5, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0.2922445957514872, "rrf_score": 0.025098039215686277, "rerank_score": -1.046599268913269, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 104, "quality_score": 55 } }, { "result_id": "bf23d2273f2e27b972048096a556da08", "position": 30, "page_position": 6, "retrieval_features": { "bm25_score": 0, "vector_score": 0.28112169729212044, "rrf_score": 0.015384615384615385, "rerank_score": -1.681182861328125, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 80, "quality_score": 55 } }, { "result_id": "5d607d9bb10f5fdb9dda0981636feba5", "position": 31, "page_position": 7, "retrieval_features": { "bm25_score": 0, "vector_score": 0.28635261736198436, "rrf_score": 0.014285714285714285, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 122, "quality_score": 55 } }, { "result_id": "3ac182eb19196a65db61ceb512d21e3a", "position": 32, "page_position": 8, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.014084507042253521, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 83, "quality_score": 55 } }, { "result_id": "7c31abdf3e3ef9d7c9ce4658312ec600", "position": 33, "page_position": 9, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2883513569831848, "rrf_score": 0.013888888888888888, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 83, "quality_score": 55 } }, { "result_id": "a860cd4b425f7d344257ea43b0c913ef", "position": 34, "page_position": 10, "retrieval_features": { "bm25_score": 0, "vector_score": 0.28949431839619044, "rrf_score": 0.0136986301369863, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 81, "quality_score": 55 } }, { "result_id": "293ab162a78995599054c8424438eff4", "position": 35, "page_position": 11, "retrieval_features": { "bm25_score": 0, "vector_score": 0.28951827946196196, "rrf_score": 0.013513513513513514, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 109, "quality_score": 55 } }, { "result_id": "8aea234391d33966bdb3186f4dddae28", "position": 36, "page_position": 12, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.013333333333333334, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 88, "quality_score": 55 } }, { "result_id": "8c2dcbfea8d976f95623491d5187b77d", "position": 37, "page_position": 13, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.013157894736842105, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 87, "quality_score": 55 } }, { "result_id": "a7483daadde7fd04a7bb51ccf0509fd7", "position": 38, "page_position": 14, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.01282051282051282, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 88, "quality_score": 55 } }, { "result_id": "d005a44c3b8ab85213b5e3db8e22185e", "position": 39, "page_position": 15, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2932748794555664, "rrf_score": 0.01282051282051282, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 122, "quality_score": 55 } }, { "result_id": "3c43e27f00377d0c420c484d3a16db35", "position": 40, "page_position": 16, "retrieval_features": { "bm25_score": 0, "vector_score": 0.293279093904548, "rrf_score": 0.012658227848101266, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 75, "quality_score": 55 } }, { "result_id": "c105e3535b716e6f76407b9a11159eb9", "position": 41, "page_position": 17, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.0125, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 62, "quality_score": 45 } }, { "result_id": "c2668784570c9d5b73bccc5765d8179f", "position": 42, "page_position": 18, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.012345679012345678, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 88, "quality_score": 55 } }, { "result_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "position": 43, "page_position": 19, "retrieval_features": { "bm25_score": 0, "vector_score": 0.293540877488798, "rrf_score": 0.012345679012345678, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 122, "quality_score": 55 } }, { "result_id": "f106c4f2159a0f9119e40bd09b4eb568", "position": 44, "page_position": 20, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.011904761904761904, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 83, "quality_score": 55 } }, { "result_id": "f0dc5f1a65b63a3dc99d009006b44864", "position": 45, "page_position": 21, "retrieval_features": { "bm25_score": 0, "vector_score": 0.29424814616154626, "rrf_score": 0.011764705882352941, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 122, "quality_score": 45 } }, { "result_id": "fe67fffa8f0de0487f438e51c90baa42", "position": 46, "page_position": 22, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.011627906976744186, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 88, "quality_score": 55 } }, { "result_id": "24070f2483e4550fbf011fdd966c0d31", "position": 47, "page_position": 23, "retrieval_features": { "bm25_score": -15.10630178451538, "vector_score": 0, "rrf_score": 0.011494252873563218, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 76, "quality_score": 55 } }, { "result_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "position": 48, "page_position": 24, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2954189425207395, "rrf_score": 0.011363636363636364, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 61, "quality_score": 55 } } ] }, "context_signature": "p7N5tNec3gXT-U-fXXXsU8Pf-vNo5h98iLQwjF1gsFo", "event_token": "p7N5tNec3gXT-U-fXXXsU8Pf-vNo5h98iLQwjF1gsFo" } }